The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter analysis of abemaciclib after progression on palbociclib in patients (pts) with hormone receptor-positive (HR+)/HER2- metastatic breast cancer (MBC).
 
Seth Andrew Wander
Consulting or Advisory Role - Foundation Medicine; InfiniteMD
 
Mark Zangardi
No Relationships to Disclose
 
Andrzej Niemierko
No Relationships to Disclose
 
Avinash Kambadakone
No Relationships to Disclose
 
Leslie SL Kim
No Relationships to Disclose
 
Jing Xi
No Relationships to Disclose
 
Apurva Kumari Pandey
No Relationships to Disclose
 
Laura Spring
Honoraria - Dava Oncology
Consulting or Advisory Role - Novartis
Research Funding - Tesaro (Inst)
Travel, Accommodations, Expenses - Novartis
 
Casey Stein
No Relationships to Disclose
 
Dejan Juric
Consulting or Advisory Role - Eisai; EMD Serono; Genentech; Ipsen; Novartis
Research Funding - Eisai; EMD Serono; Genentech; Novartis; Placon; Takeda
 
Irene Kuter
No Relationships to Disclose
 
Beverly Moy
Consulting or Advisory Role - Dark Canyon Labs (I); MOTUS (I); Remedy Partners (I)
Research Funding - Puma Biotechnology (Inst)
 
Therese Marie Mulvey
Expert Testimony - Morrison Mahoney
Other Relationship - Academy of Managed Care Pharmacy
 
Neelima Vidula
Patents, Royalties, Other Intellectual Property - Research funding to the institution: -Radius -Daewha -Merck -Pfizer (Inst); Research funding to the institution: -Radius -Daewha -Merck -Pfizer (Inst)
 
Steven J. Isakoff
Consulting or Advisory Role - Abbvie; Genentech/Roche; Hengrui Therapeutics; Immunomedics; Myriad Genetics; PharmaMar; Puma Biotechnology
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Genentech (Inst); Merck (Inst); OncoPep (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Megan Yuen
No Relationships to Disclose
 
Adam Brufsky
Consulting or Advisory Role - Agendia; Bayer; Bioarray Therapeutics; bioTheranostics; Celgene; Eisai; Genentech/Roche; Genomic Health; Lilly; Merck; Myriad Pharmaceuticals; NanoString Technologies; Novartis; Pfizer; Puma Biotechnology
 
Cynthia X. Ma
Consulting or Advisory Role - AstraZeneca; Biovica; Lilly; Merck; Novartis; Pfizer; Pfizer; Puma Biotechnology; Syndax; Tempus
Research Funding - Eisai (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Novartis; pfizer; Syndax
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Agendia; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Genentech; Genomic Health; GRAIL; HERON; Immunomedics; Ipsen; Jounce Therapeutics; Lilly; Merck; Myriad Pharmaceuticals; Novartis; Odonate Therapeutics; Pfizer; Puma Biotechnology; Roche; Seagen; Syndax
Consulting or Advisory Role - Abbvie; Agendia; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Genentech; Genomic Health; GRAIL; HERON; Immunomedics; Ipsen; Jounce Therapeutics; Lilly; Merck; Myriad Pharmaceuticals; Novartis; Odonate Therapeutics; Pfizer; Puma Biotechnology; Roche; Seagen; Syndax
Speakers' Bureau - AstraZeneca; Lilly; Novartis
Research Funding - Seagen (Inst)
Travel, Accommodations, Expenses - Abbvie; Agendia; Amgen; Celgene; Eisai; Eisai; Genomic Health; GRAIL; Ipsen; Jounce Therapeutics; Lilly; Myriad Pharmaceuticals; Novartis; Pfizer; Puma Biotechnology; Seagen
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Merck (Inst); Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - bioTheranostics